Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients.
Simon G P FunnellW E DowlingC Muñoz-FontelaP-S GsellDonald E IngberG A HamiltonLeen DelangJ Rocha-PereiraS KapteinK H DallmeierJ NeytsK RosenkeEmmie de WitHeinrich FeldmannPauline MaisonnasseRoger Le GrandMatthew B FriemannC M ColemanPublished in: Nature communications (2020)
Keyphrases